Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn which travel credit cards come with no annual fees. Find the perfect card to enhance your travel experience!
27,014 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As Cardano prepares to roll out its Midnight privacy network this week, the cardano shorts spike highest reading sinc...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Elon Musk is stirring the pot once again with Terafab, the newest idea from elon that aims to redefine manufacturing ...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
Arm Holdings stunned markets with a powerful run, then pulled back after earnings. This guide breaks down whether thi...
Learn how to read a 2026 earnings call transcript with a practical, real-world lens. We break down a hypothetical GHI...
XRP steadies near key support and eyes a breakout above $1.60 this week. This week's ripple (xrp) price predicti...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
Investors are buzzing about the huge news trade desk developments. This guide breaks down what it could mean for TT D...